Journal of Clinical Psychopharmacology

Article	Citations
Clozapine Use Among Individuals With Schizophrenia Occurring on the Background of Intellectual Disability and Rare Genetic Variation	45
Treatment of Cannabis Hyperemesis Syndrome Using Haloperidol in a Pregnant Patient	34
Trazodone and Mianserin for Delirium	34
The Treatment of Iatrogenic Anorgasmia in a Male Patient on Clozapine for Treatment-Resistant Schizophrenia	29
Pharmacokinetic-Interactions of BI 425809, a Novel Glycine Transporter 1 Inhibitor, With Cytochrome P450 and P-Glycoprotein Substrates	23
Question	20
Dysphagia to Liquids Only Associated With Olanzapine	20
Hodgkin Lymphoma in Patients Receiving Clozapine Treatment	20
Clozapine-Associated Myocarditis in a Patient With Poor Metabolism During Fast Titration	19
Transitioning From a Standard Low-Dose to a Rapid Low-Dose Buprenorphine Initiation in a Hospital Setting—A Case Report	17
Plasma Concentrations of Tranylcypromine in Depressed Patients With Chronic Kidney Disease	15
Comparison of Weight-Based Valproic Acid Dosing in Treatment of Mental Illness Among Obese and Nonobese Patients	15
Valbenazine, Fluphenazine, and Possible Neuroleptic Malignant Syndrome in a 58-Year-Old Woman	14
Author Index 2022	13
Possibly Misleading Pharmaceutical Advertising On TV	12
Postinjection Syndrome After Paliperidone?	12
Erratum: What Is the Current State of Evidence Regarding Any Mood-Improving Properties of GLP-1 Receptor Agonists, and Are Psychiatrists Prescribing Them?	12
Better Approaches to Derisking Psychiatric Drug Development are Needed, Not New Funding Mechanisms	12
Beneficial Effect of Quetiapine on Sleep, Anxiety, Depression and Myalgia Symptoms in a Patient With Post–COVID-19 Condition	12
Zopiclone Discontinuation–Associated Transient Sleepwalking Behavior	11
Drug-Associated Liver Injury Related to Antipsychotics	11
Recognition of Clozapine-Associated Eosinopenia in Patients With Treatment-Resistant Schizophrenia	11
Polypharmacy Among Patients With Major Depressive Disorder and Co-occurring Substance Use Disorders in a Psychiatric Hospital Setting	11
Escitalopram-Associated Drug Rash	11
Postpartum Depression and Antibiotics Overuse in Pakistan: Exploring a Potential Nexus	10

Drug Interaction Between Clozapine and Rifampicin	10
Late-Onset Polyserositis Emerging During Long-Term Clozapine Treatment and Persisting After Clozapine Discontinuation	10
Celebrating 70 Years of the First Publication on Antipsychotic Treatment in North America by Heinz E. Lehmann and Gorman E. Hanrahan: Would Their Methodology Still Be Conceivable?	10
Suicidal Ideation and Self-harming Thoughts With Valbenazine Use	10
Duloxetine-Associated Erosive Gastritis and Gastroesophageal Reflux	10
Mirtazapine as a Treatment for Adolescent Depression and PTSD in Juvenile Detention Settings	10
Thoughts on the Value of Case Series in the Literature	10
Prediction of Corresponding Dose of Transdermal Blonanserin to Oral Dose Based on Dopamine D2 Receptor Occupancy	10
Mild Neutropenia After Suicide Attempt With 900 Milligrams Intake of Mirtazapine	10
Effect of Valproate Coprescription on Clozapine Pharmacokinetics in Clinical Practice	10
Time to Rehospitalization for Different Oral Risperidone Dosing Frequencies in Patients With Schizophrenia	10
Mood Swings and Irritability in a Patient With Cystic Fibrosis on Elexacaftor-Tezacaftor-Ivacaftor Therapy	9
Treatment of Acute Intermittent Porphyria–Associated Anxiety Disorder With Gabapentin	9
Clozapine Once-Daily Versus Divided Dosing Regimen	9
SALUTE TO OUR REVIEWERS	9
Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations and the Clozapine/Norclozapine Ratio	9
Effect of Cigarette Smoking on Clozapine Dose and on Plasma Clozapine and N-Desmethylclozapine (Norclozapine) Concentrations in Clinical Practice: Erratum	9
Neuroleptic Malignant Syndrome Associated With Lurasidone	9
Clinical and Demographic Predictors of Early Clozapine Discontinuation Across Mood and Psychotic Disorders	8
Restless Legs Syndrome Associated With Brexpiprazole	8
Antidepressive Effectiveness of Amisulpride, Aripiprazole, and Olanzapine in Patients With Schizophrenia Spectrum Disorders	8
Untreated Mental Illness Has Created a National Tragedy	8
Prolonged Agranulocytosis Despite a Granulocyte Colony-Stimulating Factor Treatment During Clozapine Treatment	8
Factors Associated With Poor Response to Clozapine in Schizophrenia	8
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104	7
Successful Treatment of Inappropriate Sexual Behavior and Disinhibition in Dementia With Paroxetine	7
Inverse Association Between Persistence With Antidepressant Medication and Onset of Chronic Pain in Patients With Depression	7
Aripiprazole as First-Line Therapy for Late-Life Depression	7
A Case of Akathisia After Administration of a Very Low Dose of Mirtazapine	7
Successful Management of ECT-Resistant Interictal Psychosis With Clozapine	7
Letter to the Editors in Response to: Flanagan RJ, Hunter S, Obee S, Reeves S. Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	7
Use of Risperidone Long-Acting Injection in the Treatment of Anorexia Nervosa: A Case Report	7
The Clinical and Economic Burden of Tardive Dyskinesia in Israel	7
Long-Term Course of Illness With Rapid-Cycling Bipolar Disorder	7
Journal of Clinical Psychopharmacology Updates	7
Severe Panic Disorder After Vaccination With the Pfizer-BioNTech Vaccine	6
Resolution of Catatonia With Cariprazine—A Case Report	6
Question	6
Clozapine- and Lithium-Associated Myoclonus	6
Mania Associated With Cariprazine	6
Olanzapine-Associated Hyperbilirubinemia in an Adolescent With Autistic Spectrum Disorder Comorbid With Schizophrenia	6
Plasma Clozapine in Treatment Refractory Schizophrenia	6
Oculogyric Crisis Associated With Clozapine: Case Report and Review of Literature	6
Clozapine-Associated Agranulocytosis	6
Postinjection Delirium/Sedation Syndrome After Paliperidone Palmitate Injection in a Bipolar Affective Disorder Patient	6
A Withdrawal Syndrome After a Switch of Phenibut to Another γ-Aminobutyric Acid Agonist	6
Limitations in Recent Study of Clozapine Use During Pregnancy	6
Use of Clozapine in Pregnancy	6
A Manic Episode With Psychotic Features Associated With Levetiracetam	6
Aripiprazole-Associated QT Prolongation in a Healthy Study Volunteer	6

A System for Rapidly Yet Rigorously Evaluating the Quality of Randomized Controlled Trials	6
Use of Sublingual Atropine Drops in Clozapine-Associated Sialorrhea in an Adolescent Patient	6
Liraglutide in Obese or Overweight Individuals With Stable Bipolar Disorder	5
The Association Between Mood Stabilizers, Sleep Quality, and Functioning in Patients With Remitted Bipolar Disorder	5
Sleep Quality After Quetiapine Augmentation in Patients With Treatment-Resistant Depression and Personality Disorders	5
Lithium-Associated Nephrogenic Diabetes Insipidus or Catatonic Stereotypical Drinking?	5
Hematological and Other Cancers in People Using Clozapine	5
Alpha Lipoic Acid for Schizophrenia	5
Incorporating Real-World Treatment Data Into Clozapine's Product Label	5
Clozapine Use in Down Syndrome	5
Clozapine Associated Periorbital Edema in First Episode Psychosis	5
Atomoxetine Associated Activation Syndrome in Adolescent Patients With ADHD	5
Therapeutic Drug Monitoring of Paliperidone in Patients With Schizophrenia in Taiwan	5
Author Index 2024	5
Haloperidol-Induced Brugada-Pattern Electrocardiogram—A Case Report and a Review of the Literature	5
COVID-19 Outcomes: Does the Use of Psychotropic Drugs Make a Difference? Accumulating Evidence of a Beneficial Effect of Antidepressants—A Scoping Review	5
Risk of Breast Cancer With Prolactin Elevating Antipsychotic Drugs	5
A Case of Hyperpyrexia Associated With Risperidone Microspheres for Injection (II)	5
Subject Index 2022	5
Valproic Acid–Associated Hyperammonemia	5
Mania-Like Reaction Secondary to Sodium Oxybate	5
Pharmacokinetics of Ketamine Transfer Into Human Milk	5
Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder	4
Combination of Long-Acting Injectable Antipsychotics in the Treatment of Psychiatric Disorders—A Systematic Review of the Literature and Case Series	4
Reversible Valproic Acid–Associated Cerebral Pseudoatrophy in a 53-Year-Old Male With Bipolar I Disorder	4
Esketamine for Unipolar Major Depression With Psychotic Features	4
Clonidine and Trihexyphenidyl in Clozapine-induced Hypersalivation	4
Combination With Long-Acting Injectable Antipsychotics and Utilization of Nonstandard Formulations as Compliance Enhancing Methods for Clozapine Users	4
Fluoxetine and Sertraline Inhibit Height Growth and Growth Hormone Signaling During Puberty	4
Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period	4
At Last, a Nondopaminergic Agent for the Treatment of Schizophrenia: The Combination of Xanomeline and Trospium (Cobenfy)	4
Deutetrabenazine Provides Long-Term Benefit for Tardive Dyskinesia Regardless of Underlying Condition and Dopamine Receptor Antagonist Use	4
Impact of Selective Serotonin-Reuptake Inhibitors in Hemorrhagic Risk in Anticoagulated Patients Taking Non–Vitamin K Antagonist Anticoagulants	4
Fixed-Dose Brexpiprazole and Sertraline Combination Therapy for the Treatment of Posttraumatic Stress Disorder	4
Exploring the Addictive Potential of Tranylcypromine	4
Characterization of Extended-Release Lorazepam	4
Neurotoxicity Related to Multidrug Association: A Case Report	4
The Need for Non-profit Psychiatric Drug Discovery and Development	4
Detecting Anxious Distress, an Important Mood Specifier	4
Can Quetiapine Prolong the Antidepressant Effect of Ketamine?	4
Reply: Misidentified Dopamine Agonists Undermine Investigation Into Aripiprazole Link With Impulse Control Disorders	4
Differentiating Depressive Symptoms From Side Effects in Individuals With Major Depressive Disorder With Postpartum Onset	4
Topiramate-Associated Acute Bilateral Angle-Closure Glaucoma	4
The Potential Role of Fluvoxamine in Clozapine-Associated Constipation	4
Protracted Psychiatric Complications Including Psychosis in a Middle-Aged Man After COVID-19 Vaccination	4
Lumbosacral Plexopathy in Clozapine Overdose: A Case Report	4
Positive Pyramidal Sign as an Unexpected Presentation in Antipsychotic-Induced Acute Dystonia	4
Article Selected to Receive the Mitchell B. Balter Award for 2022	4
The Potential Benefits of Chromium and Selenium Supplementation Across Psychiatric Disorders and Symptoms	3
The Switch From Paliperidone Long-Acting Injectable 1- to 3-Monthly	3
New Onset of Seizures and Psychosis in a Patient Who Is Coprescribed Atomoxetine and Bupropion	3
The Impact of Once Daily Dosing on Protein Binding of Clozapine and Norclozapine	3
Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia	3
Tardive Dyskinesia Suppressed With Ginkgo Biloba	3
Plasma Clozapine and Norclozapine After Use of Either Crushed Tablets or Suspension Compared With Tablets	3
Recurrent Guaifenesin-Associated Nephrolithiasis Complicates Dextromethorphan Abuse	3
Ketamine as a Potential Neuromodulatory Treatment for Long COVID Neuropsychiatric and Neuropathic Symptoms	3
REL-1017 (Esmethadone) May Rapidly Reduce Dissociative Symptoms in Adults With Major Depressive Disorder Unresponsive to Standard Antidepressants	3
Toxidrome of an Easily Obtainable Nootropic	3
How Does Drug Company Marketing Affect Physician Prescribing?	3
Second-Generation Antipsychotic Long-Acting Injection Reduced the Time of Restrictive Interventions in Patients With Schizophrenia	3
Methylphenidate-Associated Syncope	3
Comparison of Psychiatric and Clinical Profiles Between People Who Use Synthetic Cathinones and Methamphetamine	3
Response to Letter to the Editors From Prof D. Taylor	3
Concentrations of Fluoxetine Enantiomers Decline During Pregnancy and Increase After Birth	3
Preventive Effects of Ramelteon, Suvorexant, and Lemborexant on Delirium in Hospitalized Patients With Physical Disease	3
Managing a Treatment-Resistant Schizophrenia Spectrum Disorder With a Hormonal Twist in a Female Patient	3
Evaluating the Quality of Randomized Controlled Trials	3
A Potential Drug-Gene-Drug Interaction Between Cannabidiol, CYP2D6*4, and Fluoxetine	3
Panic Disorder Seeks More Specific Drugs for Treatment	3
Assessing Adherence to Clozapine	3
A Case of Acute Conditioned Dyspnea During Tracheostomy Weaning Treated Successfully With Adjunctive Mirtazapine	3
A Review of Evidence and an Algorithm for Use of Psychopharmacology in the Treatment of Tobacco Use Disorder in Behavioral Health Settings	3
The Management of Very Early-Onset Schizophrenia With an Olanzapine and Amisulpride Combination	3
Semaglutide Misuse in Atypical Anorexia Nervosa—A Case Report	3
Efficacy of Brexpiprazole Combination Therapy on Anhedonia in a Case of Treatment Resistant Bipolar II Depression	3
Improving Result Turnaround Time as a Crucial Factor to Increasing Clozapine Therapeutic Drug Monitoring in Hospitalized Patients	3
Seizure, Rhabdomyolysis, and Hypoglycemia in a Patient With Venlafaxine Poisoning	3
Pramipexole as an Augmentation Strategy to Electroconvulsive Therapy in the Treatment of Bipolar Depression Complicated With Parkinsonism	3
Ketamine and Esketamine for Depression in Daily Practice	3

Health Alert: Microdose Products Leading to Acute Illness and Hospitalizations Across the United States	3
Journal of Clinical Psychopharmacology Updates	3
Relapse of Tardive Dyskinesia Following Successful Treatment With Amantadine	3
High-Dose Methylphenidate and Carboxylesterase 1 Genetic Variability in Patients With Attention-Deficit/Hyperactivity Disorder	3
Journal of Clinical Psychopharmacology Updates	3
Growing Concerns Over Valproate Teratogenicity Present an Opportunity for Lithium	3
Impact of Prior Psychiatric Diagnoses on the Incidence of Dissociative Symptoms Associated With Analgesic Ketamine Infusions in a Surgical Intensive Care Unit	3
A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants	3
You Shall Not Turn a Blind Eye to Intraocular Pressure	3
Severe Alprazolam Withdrawal With Delirium and Psychosis	3
Exploratory Case Series Assessing the Potential Interaction Between Lithium and Sodium-Glucose Cotransporter-2 Inhibitors	2
Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia	2
Clozapine Rechallenge or Continuation Despite Neutropenia, an Extended Follow-up of a Consecutive Quebec Case Series	2
Clinician Reasons for Stopping Clozapine	2
A Phase 2 Randomized Trial of NBI-1065846 (TAK-041) in Patients With Anhedonia Associated With Major Depressive Disorder	2
Hypotension and Peripheral Edema With Moclobemide	2
Statistical Versus Clinical Significance	2
Efficacy and Safety of Valbenazine in Japanese Patients With Tardive Dyskinesia and Schizophrenia/Schizoaffective Disorder or Bipolar Disorder/Depressive Disorder	2
Adolescent Aripiprazole-Associated Rhabdomyolysis Without Neuroleptic Malignant Syndrome	2
The Use of Classic Psychedelics for Depressive and Anxiety-Spectrum Disorders	2
Acute Psychosis After Immunization With Whole-Virion Inactivated COVID-19 Vaccine; A Case Report From Central India	2
Reply to “All Patients With Catatonia Deserve Proper Diagnosis, Theragnosis, and Prognosis”	2
Antidepressant Poisoning Trends in Pediatric Intensive Care	2
A Within-Subject Before-After Study of the Impact of Antidepressants on Hemoglobin A1c and Low-Density Lipoprotein Levels in Type 2 Diabetes	2
Characteristics of Ongoing Clinical Trials of Psychogenic Substances for Psychiatric Disorders	2
A Call for the Study of Zuranolone as a Novel Treatment for Premenstrual Dysphoric Disorder	2
Modafinil Use in an Adolescent With Major Depressive Disorder	2
Cariprazine-Associated Obsessive-Compulsive Symptoms in a Patient With Bipolar Disorder	2
Risk of Neutropenia Associated With Duloxetine	2
Efficacy, Safety, and Tolerability of Centanafadine Sustained-Release Tablets in Adults With Attention-Deficit/Hyperactivity Disorder	2
Effects of a Single Dose of Ayahuasca in College Students With Harmful Alcohol Use	2
Gastrointestinal Hemorrhage After Antidepressant Drug Use	2
Critical Feedback on Article by Lee and Colleagues: “Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia”	2
Levodopa Augmentation of Antipsychotics for Persistent Negative Symptoms in Schizophrenia	2
Ischemic Priapism With Therapeutic Serum Concentrations of Psychotropic Medications	2
Effects of Age, Sex, and Comedication on the Plasma Concentrations of Olanzapine in Chinese Patients With Schizophrenia Based on Therapeutic Drug Monitoring Data	2
Effect of Coffee and Chocolate Ingestion on Clozapine Dose and on Plasma Clozapine and Norclozapine Concentrations in Clinical Practice	2
Citalopram-Associated Hyponatremia Presenting as Distal Extremity Numbness	2
Question	2
Treatment History Characteristics Associated With Use of Isocarboxazid	2
Addressing Metabolic Comorbidity in Individuals With Intellectual and Developmental Disability on Antipsychotics	2
Pleural Effusion Associated With Divalproex Sodium	2
Semaglutide-Mediated Lithium Toxicity	2
Risk of Mania After Methylphenidate in Patients With Bipolar Disorder	2
Advancing the Development of New Medications to Treat Psychiatric Illness	2
Effectiveness and Tolerability of Lurasidone for Bipolar Types I and II and Other Specified Bipolar Depression	2
Citalopram Associated with the Development of Tinnitus in an Adolescent Girl	2
Antimicrobial Exposure and Risk for Incident Major Depressive Disorder	2
Reply to “Xanomeline/Trospium Combination: Not Non-dopaminergic but a Novel Antidopaminergic Treatment for Schizophrenia”	2
Sleep-wake Disorders	2
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and Adolescents	2
A First Trimester Exposure to Ketamine and Esketamine for Depression	2
Effects of Adjunctive Brexpiprazole on Individual Depressive Symptoms and Functioning in Patients With Major Depressive Disorder and Anxious Distress	2
Fact Versus Fear	2
Obesity Associated With Symptomatic Remission in Clozapine-Treated Individuals With Treatment-Resistant Schizophrenia	2
Zuranolone Concentrations in the Breast Milk of Healthy, Lactating Individuals	2
Sertraline-Associated Burning Mouth Syndrome	2
52-Week Open-Label Safety and Tolerability Study of Centanafadine Sustained Release in Adults With Attention-Deficit/Hyperactivity Disorder	2
Catatonia Associated With Valbenazine Treatment	2
Clozapine-Associated Eosinophilia at a Movement Disorders Clinic	2
Electrocardiographic Changes During Initiation of Lithium Augmentation of Antidepressant Pharmacotherapy	2
Fifty-Nine-Year-Old Woman With Concurrent Administration of Cobicistat and Dexamethasone Potentially Leading to Mania	2
Evaluation and Comparison of the Effectiveness of Atropine Eye Drops, Ipratropium Bromide Nasal Spray, and Amitriptyline Tablet in the Management of Clozapine-Associated Sialorrhea in Patients With Re	2
Blepharospasm Arising From Escitalopram Use	2
Metabolic Problems Among People With Treatment-Resistant Schizophrenia are Not Unique to Clozapine	2
Severe Urinary Retention Associated With Combined Treatment With Escitalopram and Quetiapine	2
Painful Ejaculation Associated With Atomoxetine and Bupropion	2
Comparison of Extrapyramidal Symptoms Among Outpatients With Schizophrenia on Long-Acting Injectable Antipsychotics	2
Agomelatine as an Effective Intervention for Psychiatric Symptoms in Postacute Sequelae of COVID-19	2
Lethal Acute Colonic Pseudo-Obstruction in a Patient Using a Combination of Olanzapine and Clozapine	2
Question	2
Question	2
Challenges With Short-term Use of Intravenous Racemic Ketamine With Psychotherapy for a Hospitalized Patient With Severe Posttraumatic Stress Disorder and Depression	2
Ketamine's Altered States Meta-Analysis	2
Myocarditis After Clozapine Initiation and mRNA SARS-CoV-2 Vaccination	2
Venlafaxine-Associated Rhabdomyolysis	2
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part I	2
“I Am Depressed”: The Many Meanings That May Underlie Variability in Response to Antidepressants	2
Further Studies of Effects of Finasteride on Mood and Suicidal Risk	2
Premature Ejaculation After Discontinuation of Venlafaxine in a Case of Bipolar Depression	2
Prebiotic Treatment in People With Schizophrenia	2
α-PVP Associated Psychosis	2
The Rise and Fall of the Age of Psychopharmacology	2
Unraveling the Optimal Treatment Approach for Depression in Schizophrenia Spectrum	2
Pimavanserin Exposure-Response Analyses in Patients With Schizophrenia	2
Question	2
Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital	2
κ-Opioid Receptor Plasma Levels Are Associated With Sex and Diagnosis of Major Depressive Disorder But Not Response to Ketamine	2
New-Onset Agranulocytosis During Long-term Treatment With Olanzapine	1
Notice of Retraction: Once-Daily High-Dose Pindolol for Paroxetine-Refractory Premature Ejaculation: A Double-Blind, Placebo-Controlled and Randomized Study	1
Genital Hair Growth in a Young Girl Treated With Methylphenidate for Attention Deficit Hyperactivity Disorder	1
Quality Assurance of Depression Ratings in Psychiatric Clinical Trials	1
Combination Treatment With Varenicline and Nicotine Patch on Smoking Cessation Outcomes in Heavy Drinkers at 26-Week Follow-up	1
Albuterol-Associated Hallucinations	1
The Association Between Stimulant Medication Use and Mortality	1